Randomised controlled trial of mesalazine in IBS.

Gut · 2016 · PMC4717362 · PMID 25533646

Europe PMC DOI

hedged sentences

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significantp=0.060so close (0.05 < p ≤ 0.1)

Using the same model to test the simple main effect, a borderline significant effect was detected at week 3 (p=0.060) and a statistical significance was detected at week 5 (p=0.038) ( figure 4 A).

also in 11,409 other papers

did not reach statistical significanceno p-value reported

There was also a trend in a better improvement of pain intensity and bloating as well as quality of life and a lower requirement of rescue medications with mesalazine, although these data did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.